BCL2L11 and cancer: The underlying biological mechanisms may include multiple possibilities, such as 1) PD-1 activation increases cancer cell apoptosis through upregulation of pro-apoptotic proteins such as BIM; 2) PD-1 activation impedes cancer cell cycle progression at the G1-S checkpoint through multiple complex mechanisms, including the upregulation of the G1 phase inhibitor p15INK4 and indirectly increasing inhibition of cyclin-dependent kinase 216,17.